INTRODUCTION {#sec1-1}
============

Pituicytomas are very rare primary tumors of the neurohypophysis and can affect both the sellar and suprasellar regions. Few cases have been described in the literature.\[[@CIT17]\] Until now there are 31 cases reported, all of them are described in [Table 1](#T0001){ref-type="table"}, which contribute to the poor characterization of the tumor and consequent diagnostic difficulties.

###### 

Summary of the reported 31 cases of pituicytoma

  Patient no.   Series (ref. no.)                             Age (year)/sex   Presentation                                                       Imaging                                                                                                                                 Resection                                              Follow up   Recurrence/complications                             Radiation therapy
  ------------- --------------------------------------------- ---------------- ------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------ ----------- ---------------------------------------------------- -----------------------------------------
  1             Hurley *et al*., 1994 ([@CIT7])               26/F             Decreased visual acuity and hemianopsia                            2-cm enhancing sellar mass, T1-isointense, T2- hyperintense                                                                             TSP/STR                                                3 year      None/transient Deficit                               5040 cGy
  2             Brat *et al*., 2000 ([@CIT2])                 55/F             Visual deficit                                                     Suprasellar, enhancing                                                                                                                  GTR                                                    1 year      None                                                 None
  3             Brat *et al*., 2000 ([@CIT2])                 30/M             Headache                                                           Suprasellar, enhancing                                                                                                                  GTR                                                    1 year      None                                                 None
  4             Brat *et al*., 2000 ([@CIT2])                 39/M             Headache                                                           Solid and cystic, intrasellar, enhancing                                                                                                TSP/GTR                                                2 year      None                                                 None
  5             Brat *et al*., 2000 ([@CIT2])                 42/M             Hypopituitarism/hemianopsia                                        Intrasellar, enlarged over 2 years of observation                                                                                       TSP/STR                                                2.5 year    2 year progression with resection                    None
  6             Brat *et al*., 2000 ([@CIT2])                 42/M             Visual deficit/decreased libido                                    Solid, suprasellar enhancing                                                                                                            STRl                                                   1 year      Re-resection for recurrence × 2 at 5 and 15 months   None
  7             Brat *et al*., 2000 ([@CIT2])                 46/M             Hypopituitarism                                                    Solid, suprasellar enhancing                                                                                                            GTR                                                    8 year      None                                                 None
  8             Brat *et al*., 2000 ([@CIT2])                 83/F             Visual deficit                                                     Suprasellar                                                                                                                             GTR                                                    2 year      None                                                 None
  9             Brat *et al*., 2000 ([@CIT2])                 48/M             Hypogonadism                                                       2-cm solid, suprasellar mass encasing vessels                                                                                           Craniotomy/STR                                         8 months    Recurrence at 5 months with subtotal re-resection    None
  10            Brat *et al*., 2000 ([@CIT2])                 51/F             Visual deficit                                                     Solid, enhancing sellar mass consistent with adenoma                                                                                    GTR                                                                Unknown                                              None
  11            Schultz *et al*.,2001 ([@CIT16])              66/M             Decreased visual acuity, visual field deficit                      2-cm enhancing, T1- isointense, T2-hyperintense                                                                                         TSP/GTR                                                2 year      None                                                 None
  12            Cenacchi *et al*., 2001 ([@CIT3])             79/F             Hypopituitarism/visual disturbances                                Unknown                                                                                                                                 TSP/GTR                                                6 months    None                                                 None
  13            Figarella- Branger *et al*., 2002 ([@CIT5])   59/M             Hypopituitarism                                                    Solid, enhancing                                                                                                                        TSP/STR                                                11 year     None                                                 None
  14            Figarella- Branger *et al*., 2002 ([@CIT5])   46/M             Decreased libido/hypogonadism                                      Solid, enhancing, suprasellar                                                                                                           GTR                                                    4 year      None/transient hemiparesis                           None
  15            Figarella- Branger *et al*., 2002 ([@CIT5])   58/M             Hypopituitarism/memory deficits                                    Solid, enhancing, mimicking posterior clinoid meningioma                                                                                GTR                                                    2 year      None/DI                                              None
  16            Uesaka *et al*., 2002 ([@CIT20])              34/M             Decreased visual acuity                                            Solid, enhancing, T1- isointense, T2-hyperintense                                                                                       TSP/STR                                                3 months    None                                                 None
  17            Katsuta *et al*., 2003 ([@CIT8])              32/F             Amenorrhea/visual field defect                                     Intrasellar, isointense T1 and T2, enhancing                                                                                            TSP/GTR                                                2 year      None/DI                                              None
  18            Ulm *et al*., 2004 ([@CIT21])                 45/M             Decreased libido/low testosterone                                  2-cm solid, enhancing, suprasellar                                                                                                      Craniotomy/STR                                         Unknown     None                                                 Stereotactic radiation
  19            Kowalski *et al*., 2004 ([@CIT9])             52/M             Panhypopituitarism                                                 Solid, heterogeneously enhancing sellar/suprasellar mass                                                                                TSP/STR                                                11 months   Recurrence                                           Fractionated radiation after recurrence
  20            Shah *et al*., 2005 ([@CIT17])                32/F             Amenorrhea/headache                                                Heterogeneously enhancing posterior pituitary mass, T1- isointense, T2-hyperintense                                                     TSP/STR                                                5 year      Recurrence with re-resection TSP                     None
  21            Shah *et al*., 2005 ([@CIT17])                45/F             Headache                                                           Enhancing sellar/ suprasellar mass, T1- isointense, T2-hypointense                                                                      TSP                                                    Unknown     Unknown                                              Unknown
  22            Chen, 2005 ([@CIT4])                          54/M             Headache                                                           Enhancing sellar/suprasellar mass                                                                                                       TSP/STR                                                16 months   None                                                 None
  23            Takei *et al*.,2005 ([@CIT18])                54/F             Incidental at autopsy                                              None                                                                                                                                    None                                                   None        None                                                 None
  24            Nakasu *et al*., 2006 ([@CIT12])              42/F             Amenorrhea                                                         Homogeneously enhancing sellar/suprasellar mass                                                                                         Craniotomy/STR                                         5 year      None                                                 None
  25            Nakasu *et al*., 2006 ([@CIT12])              62/F             Headache/fatigue                                                   Homogeneously enhancing sellar/suprasellar mass                                                                                         Craniotomy/STR                                         1.5 year    None/transient DI/hypopituitarism                    None
  26            Benveniste *et al*., 2006 ([@CIT1])           47/M             Hemorrhage/low LH/FSH                                              Hemorrhagic suprasellar mass with IVH                                                                                                   Craniotomy/STR                                         None        Unknown                                              None
  27            Gibbs *et al*., 2006 ([@CIT6])                64/M             Bitemporal hemianopsia                                             Homogeneously enhancing 3-cm suprasellar mass, T1- isointense, T2-hyperintense, angiogram hypervascular capillary blush from ICA only   Cranio-orbitozygomatic craniotomy/GTR, very vascular   Unknown     Unknown                                              Unknown
  28            Thiryayi at al, 2007 ([@CIT19])               77/M             Hypogonadism Quadrantonopia bitemporal inferiorSuprasselar level   TSP/ STR                                                                                                                                TSP/ STR                                               None        None                                                 None
  29            Wolfe *et al*.2008 ([@CIT22])                 71/F             Decreased visual acuity and visual field defects                   Solid, enhancing mass                                                                                                                   TSP/STR                                                1.5 year    None                                                 None
  30            Orrego J. T. 2009([@CIT14])                   55/M             Decreased libido Dysfunction erectic ginecomastia                  Suprasella mass isointense on T1                                                                                                        TSP/STR                                                None        None                                                 None
  31            Brandao and Braga *et al*. 2010               17/M             Headache visual Disturbance                                        Contrast-enhance solid sellar                                                                                                           TSP/STR                                                24 months   None                                                 None

TSP: Transphenoidal Approach, STR: subtotal resection, GTR: gross-total resection

Pituicytomas originate from pituicytes, modified glial cells derived from ependymal lineage which are found in the stalk and posterior lobe of pituitary gland.\[[@CIT13][@CIT15]\] On neuroimaging, pituicytomas are solid, uniformly contrast-enhancing masses. They are histologically low grade, featuring only mild nuclear atypia and no mitotic activity.\[[@CIT2]\] We describe here a case of pituicytoma diagnosed at our service and discuss it in relation to the data available in the literature.

CASE REPORT {#sec1-2}
===========

Description {#sec2-1}
-----------

**Clinical presentation:** A 17-year-old boy was reported with a history of persistent headache and recent onset of visual disturbances. Examination revealed bitemporal heteronymous hemianopsia and swelling of the left optic papilla. The remaining neurological exam was normal. Magnetic resonance imaging (MRI) of the brain revealed a contrast-enhancing, expansive solid sellar and suprasellar mass with an intermediate signal intensity on T1- and T2-weighted images, measuring about 2.6 cm × 1.6 cm × 1.5 cm \[[Figure 1](#F0001){ref-type="fig"}\]. The mass occupied the sella turcica, extending from the suprasellar cisterna and compressing optic chiasm and chiasmatic recess of the third ventricle. Endocrinological analysis demonstrated mild hyperprolactinemia (31.75 ng/ml, reference: 2.1--17.7 ng/ml), with the other pituitary hormones being normal.

![Preoperative MRI.](SNI-1-79-g001){#F0001}

**Surgery:** The patient was submitted to partial transphenoidal resection of the tumor. The surgical aspect did not differ from that found in a pituitary adenoma, both in consistency, color, as well as in bleeding. The cavity was filled with autologous fat.

**Postoperative period:** The patient presented no major complications, except for diabetes insipidus detected during the early postoperative period which was completely controlled. Residual tumor was identified, but no tumor recurrence was observed after a follow-up period of 24 months.

**Pathological anatomy:** Microscopy showed a predominantly fusocellular tumor consisting of pleomorphic cells with a fascicular growth pattern. The cells were characterized by abundant eosinophilic cytoplasm, vesiculous nucleo with mild atipia and clearly visible nucleoli. Mitotic figures were occasionally observed \[[Figure 2](#F0002){ref-type="fig"}\].

![(A) Microscopic view showing a fusocellular tumor consisting of pleomorphic cells with a fascicular growth pattern. (B) Cells with eosinophilic citoplasm and clearly visible nucleoli. (C) Immunohistochemical reaction with S-100 protein.](SNI-1-79-g002){#F0002}

The material was analyzed by immunohistochemical study. Antibodies against several antigens were tested and are shown in [Table 2](#T0002){ref-type="table"}. Most tumor cells were reactive to the cell proliferation antigen Ki-67 and to protein S-100. There was no reaction to the other antigens tested, including glial fibrillary acidic protein (GFAP). According to the criteria proposed by Brat *et al*.,\[[@CIT4]\] the diagnosis of pituicytoma was thus confirmed.

###### 

Antibodies tested in immunohistochemical study

  Antibodies                                                 Clone        Results
  ---------------------------------------------------------- ------------ ----------
  Proliferation antigen Ki-67                                MIB-1        Positive
  Epithelial membrane antigen -- EMA                         E29          Negative
  Cytokeratins of 40, 48, 50, and 50.6 kDa                   AE1/AE3      Negative
  Protein S-100                                              Policlonal   Positive
  Glial fibrillary acidic protein -- GFAP                    Policlonal   Negative
  Synaptophysin                                              Sy38 AFP     Negative
  CD68 -- lysosomal protein                                  KP1          Negative
  Nerve growth factor receptor                               NGFR5        Negative
  Melanoma                                                   PNL2         Negative
  Melanoma-associated gp100 antigen                          HMB-45       Negative
  Melanoma antigen recognized by T cells -- Melan A/MART-1   A103         Negative

DISCUSSION {#sec1-3}
==========

The neurohypophysis comprises the posterior portion of the pituitary, infundibulum, and tuber cinerium.\[[@CIT7][@CIT17]\] The cellular elements that form the posterior part of the pituitary include microglia, pituicytes, and terminal axons of secretory neurons of the hypothalamus. Pituicytes are modified microglial cells that occupy perivascular areas of the neurohypophysis and participate in the regulation of the release of hypothalamic hormones. The cells are spindle shaped and normally react to GFAP.\[[@CIT2][@CIT6]\] Five types of pituicytes have been described based on the histopathological criteria of Takei *et al*.,\[[@CIT7][@CIT10][@CIT18]\] (1) major pituicytes, the most common type characterized by an oval or irregular nucleus, distinct nucleoli, and cytoplasm containing various organelles; (2) dark pituicytes which present the same structure as major pituicytes, but have an electron-dense cytoplasm; (3) oncocytic pituicytes characterized by a large number of mitochondria; (4) ependymal pituicytes which are rudimentary ependymal cells; and (5) granular pituicytes which contain numerous electron-dense granules and give origin to granular cell tumors or choristomas.

The most common pituitary tumors are adenomas originating from the adenohypophysis. Although rare, posterior pituitary tumors include hamartomas, craniopharyngiomas, germinomas, granular cell tumors, meningiomas, pituicytomas, and pilocytic astrocytomas.\[[@CIT2][@CIT7]\]

Few cases of primary tumors of the neurohypophysis have been described, a fact impairing the classification of these tumors. So far, 30 cases of pituicytomas have been published \[[Table 1](#T0001){ref-type="table"}\].\[[@CIT1][@CIT3][@CIT5][@CIT9][@CIT11][@CIT12][@CIT14][@CIT16][@CIT19]--[@CIT22]\] In 2000, Brat *et al*.,\[[@CIT2]\] described nine cases of pituicytomas and provided a more precise and detailed characterization of the clinical and pathological findings related to this tumor. In addition, the authors proposed a clearer and more objective definition of the tumor.\[[@CIT6][@CIT8]\]

Pituicytomas are rare, noninfiltrative tumors of glial origin, which arise in the neurohypophysis that comprises the posterior region of the pituitary and the pituitary stalk.\[[@CIT2]\] In the past, the term pituicytoma frequently included granular cell tumors or choristomas and pilocytic astrocytomas.\[[@CIT6]\] Today, this term is reserved for low-grade glial tumors classified as grade I by the World Health Organization and differing from astrocytomas.\[[@CIT11]\] Thus, as in the present case, pituicytomas are solid well-defined tumors, which appear isointense on T1-weighted MRI and are characterized by marked vascular proliferation and intense contrast enhancement. These findings are nonspecific and confirmation by anatomopathological analysis is necessary.\[[@CIT6][@CIT11]\]

Histologically, pituicytomas are characterized by spindle-shaped cells arranged in interlacing fascicles. Nuclei is oval to elongated with a mild irregularity. The citoplasm is eosinophilic and homogeneous which presents little or no granulation or vacuolization and necrosis is absent.\[[@CIT2]\] Pituicytomas are histologically classified as low-grade gliomas which present little nuclear atypia and rare mitotic activity. Most tumor cells are reactive to the cell proliferation antigen Ki-67 and to protein S-100. The cells normally react to GFAP and present little or no cytoplasmic reactivity to epithelial membrane antigen (EMA). In the series described by Brat *et al*.,\[[@CIT2]\] one of the nine cases showed no reactivity to GFAP and wide variation in the intensity of the reaction was observed in the remaining eight positive cases. In the present patient, the tumor consisted of spindle-shaped cells with a fascicular organization and abundant granular cytoplasm and showed intense positivity to the Ki-67 and protein S-100 antigens, findings compatible with pituicytoma, and no reactivity to EMA or GFAP.

The most common clinical presentation was headache and bitemporal hemianopsia due to compression of the optic chiasm.\[[@CIT11]\] Other signs frequently observed are pan-hypopituitarism and mild hyperprolactinemia.\[[@CIT2]\] The patient may even be completely asymptomatic, and the tumor is detected incidentally. The present patient had mild hyperprolactinemia, with the other pituitary hormones being normal, associated with persistent headache and bitemporal hemianopia. These findings, together with the imaging detection of a solid and well-delimited mass in the sellar region, may lead to the clinical diagnosis of pituitary adenoma. The indicated treatment is surgery which can be performed by the transsphenoidal approach. The present patient underwent transsphenoidal resection of the tumor. Tumor consistency and increased bleeding observed during surgery are essential data that help the pathologist with the diagnosis of the tumor. Some authors have reported a greater bleeding tendency of these tumors during surgery.\[[@CIT7]\] In the present case, no perioperative alterations that would distinguish the tumor from a macroadenoma were observed and the diagnosis was exclusively made by histological analysis.

No tumor recurrence was observed in the related case after a follow-up period of 24 months. Although few studies are available in the literature, data suggest a high rate of tumor recurrence after partial resection and a good prognosis, with little or no recurrence, after total resection.\[[@CIT4]\]

CONCLUSION {#sec1-4}
==========

Pituicytomas are rare tumors of the neurohypophysis derived from pituicytes. Their clinical presentation resembles that of non-functional pituitary adenomas, but these two types of tumors are histologically well distinct. Surgery is the indicated treatment with a good prognosis if the tumor is completely resected.
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